会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • PHOSPHORESCENT COMPOUND
    • 磷化合物
    • US20140231755A1
    • 2014-08-21
    • US13798972
    • 2013-03-13
    • UNIVERSAL DISPLAY CORPORATION
    • Chuanjun XIABert Alleyne
    • H01L51/00
    • H01L51/0085C07F15/0033C09K11/06C09K2211/185H01L51/5016H01L51/5024
    • A metal iridium complexes, devices containing the same, and formulations including the same described. The complexes can have the formula Ir(L1)n(L2)3−n, wherein the first ligand L1 has Formula I, the second ligand L2 has Formula II, L1 is different from L2; R1 is a partially or fully deuterated group consisting of alkyl and cycloalkyl; R2 represents mono, di, tri substitutions or no substitution; R3, R4 and R5 each represent mono, di, tri, tetra substitutions or no substitution; R2 and R3 are each independently selected from the group consisting of hydrogen, deuterium, alkyl, cycloalkyl, and combinations thereof; R4 and R5 are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and n is 1 or 2. Homoleptic, tris-iridium complex including deuterated alkyl groups are also described.
    • 金属铱配合物,含有它们的装置,以及包含上述相同的配方。 络合物可以具有式Ir(L1)n(L2)3-n,其中第一配体L1具有式I,第二配体L2具有式II,L1不同于L2; R1是由烷基和环烷基组成的部分或完全氘化的基团; R2代表单,二,三取代或不取代; R 3,R 4和R 5各自表示单,二,三,四取代或不取代; R2和R3各自独立地选自氢,氘,烷基,环烷基及其组合; R 4和R 5各自独立地选自氢,氘,卤素,烷基,环烷基,杂烷基,芳基烷基,烷氧基,芳氧基,氨基,甲硅烷基,烯基,环烯基,杂烯基,炔基,芳基,杂芳基,酰基,羰基, 羧酸,酯,腈,异腈,硫烷基,亚磺酰基,磺酰基,膦基及其组合; 并且还描述了包括氘化烷基的同颂三铱络合物。